U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H9NO
Molecular Weight 147.1739
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INDOLE-3-CARBINOL

SMILES

OCC1=CNC2=C1C=CC=C2

InChI

InChIKey=IVYPNXXAYMYVSP-UHFFFAOYSA-N
InChI=1S/C9H9NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-5,10-11H,6H2

HIDE SMILES / InChI
Indole-3-carbinol (I3C), a common phytochemical in cruciferous vegetables, and its condensation product, 3,3'-diindolylmethane (DIM) exert several biological activities on cellular and molecular levels, which contribute to their well-recognized chemoprevention potential. ndole-3-carbinol is used for prevention of breast cancer, colon cancer, and other types of cancer. The National Institutes of Health (NIH) has reviewed indole-3-carbinol as a possible cancer preventive agent and is now sponsoring clinical research for breast cancer prevention. Indole-3-carbinol is also used for fibromyalgia, tumors inside the voice box (laryngeal papillomatosis) caused by a virus, tumors inside the respiratory tract (respiratory papillomatosis) caused by a virus, abnormal cell growth in the cervix (cervical dysplasia), and systemic lupus erythematosus (SLE). Indole-3-carbinol scavenges free radicals and induces various hepatic cytochrome P450 monooxygenases. Specifically, this agent induces the hepatic monooxygenase cytochrome P4501A1 (CYP1A1), resulting in increased 2-hydroxylation of estrogens and increased production of the chemoprotective estrogen 2-hydroxyestrone. Accumulating evidence indicates that the antitumor activity of indole-3- carbinol is attributable to its ability to interfere with multiple oncogenic signaling pathways governing cell cycle progression, survival, invasion, and other aggressive phenotypes of cancer cells. Reported signaling targets of indole-3- carbinol in various cancer cell lines include EGFR/Src, Akt/NF-B, stress responses, elastase, and Rho kinase. Moreover, indole-3-carbinol functions as a negative regulator of estrogen action in hormonesensitive cancer cells through the inhibition of estrogen receptor (ER)-alpha signaling and/or induction of cytochrome P-450-mediated estrogen metabolism, suggesting its clinical use in hormone-sensitive cancers.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
262 ng/mL
800 mg single, oral
dose: 800 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
510 ng/mL
1200 mg single, oral
dose: 1200 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
61 ng/mL
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
69 ng/mL
400 mg 2 times / day multiple, oral
dose: 400 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
607 ng/mL
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
93 ng/mL
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1608 ng × h/mL
800 mg single, oral
dose: 800 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
3212 ng × h/mL
1200 mg single, oral
dose: 1200 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
329 ng × h/mL
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
372 ng × h/mL
400 mg 2 times / day multiple, oral
dose: 400 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
3376 ng × h/mL
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
364 ng × h/mL
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
4.2 h
800 mg single, oral
dose: 800 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
5 h
1200 mg single, oral
dose: 1200 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
3.8 h
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
6 h
400 mg 2 times / day multiple, oral
dose: 400 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
5.7 h
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
2 h
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
3,3'-DIINDOLYLMETHANE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells.
2004-07
Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results.
2004-06
Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in singapore chinese.
2004-06
Effects of dietary anticarcinogens and nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases.
2004-05-27
Inhibition of MUC1 expression by indole-3-carbinol.
2004-05-10
Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein.
2004-03-16
Endogenous and dietary indoles: a class of antioxidants and radical scavengers in the ABTS assay.
2004-03
Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats.
2004-03
Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium.
2004-03
Established and potential strategies against papillomavirus infections.
2004-02
Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol.
2004
Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells.
2003-12-01
Broccoli compound inhibits HSV.
2003-11
A selective irreversible inhibitor targeting a PDZ protein interaction domain.
2003-10-08
Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men.
2003-10
Chemoprevention of gastrointestinal malignancies.
2003-09
Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas.
2003-08-05
The disposition and metabolism of 2-amino-3-methylimidazo-[4,5-f]quinoline in the F344 rat at high versus low doses of indole-3-carbinol.
2003-08
Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3'-diindolylmethane in sprague-dawley rats.
2003-07
Arsenate reduction in human erythrocytes and rats--testing the role of purine nucleoside phosphorylase.
2003-07
Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
2003-06-06
Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP.
2003-06-05
Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells.
2003-06
Cervical dysplasia: early intervention.
2003-05
Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver.
2003-05
Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma.
2003-04-25
Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun.
2003-04
Beneficial and adverse effects of chemopreventive agents.
2003-03-12
Mechanism-based in vitro screening of potential cancer chemopreventive agents.
2003-03-12
Chemoprevention of colon cancer by Korean food plant components.
2003-03-12
A high-throughput cell-based reporter gene system for measurement of CYP1A1 induction.
2003-03-12
The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line.
2003-03
The rainbow trout (Oncorhynchus mykiss) tumor model: recent applications in low-dose exposures to tumor initiators and promoters.
2003-02-25
Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells.
2003-01-30
Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol.
2003-01-28
Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line.
2003-01-14
Convenient synthesis of 5,6,11,12,17,18- hexahydrocyclononal[1,2-b:4,5-b':7,8-b'']triindole, a novel phytoestrogen.
2003-01-10
Role of salicylic acid in systemic resistance induced by Pseudomonas fluorescens against Fusarium oxysporum f. sp. ciceri in chickpea.
2003
Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
2003
Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells.
2003
Antigenotoxic potential of certain dietary constituents.
2003
Differential effects of vegetable-derived indoles on the induction of quinone reductase in hepatoma cells.
2002-12
Plant-derived biomolecules in fermented cabbage.
2002-11-06
Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
2002-11
Why phase II trials in cervical chemoprevention are negative: what have we learned?
2002-11
Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells.
2002-10
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol-. Certain health supplements may cause both carcinogenic and anticarcinogenic effects.
2002-10
Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation.
2002-09-15
Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
2002-08
Lack of chemoprevention of indole-3-carbinol in N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.
2002
Patents

Sample Use Guides

For treating abnormal cells on the surface of the cervix (cervical dysplasia): 200-400 mg per day has been used. However, 200 mg seems to be as effective as the higher dose.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Treating MCF-7 cells with 100 uM Indole-3-carbinol reduced ER-α mRNA expression by approximately 60%. https://www.ncbi.nlm.nih.gov/pubmed/16488130compared to controls.
Using mouse liver microsomes in an NADPH-fortified reaction mixture, Indole-3-carbinol inhibited, in a concentration-dependent manner, CCl4-initiated lipid peroxidation, with 50% inhibition at 35-40 uM Indole-3-carbinol.
Name Type Language
NSC-525801
Preferred Name English
INDOLE-3-CARBINOL
VANDF   WHO-DD  
Common Name English
3-HYDROXYMETHYLINDOLE
Systematic Name English
1H-INDOLE-3-METHANOL
Systematic Name English
INDOLE-3-CARBINOL [VANDF]
Common Name English
INDOLE-3-METHANOL
Systematic Name English
I3C
Common Name English
Indole-3-Carbinol [WHO-DD]
Common Name English
INDOLE 3-CARBINOL
Common Name English
Classification Tree Code System Code
DSLD 473 (Number of products:104)
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
NCI_THESAURUS C68534
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
Code System Code Type Description
SMS_ID
100000128243
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
ECHA (EC/EINECS)
211-836-2
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
WIKIPEDIA
INDOLE-3-CARBINOL
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
DAILYMED
C11E72455F
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
CAS
700-06-1
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
DRUG BANK
DB12881
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
EPA CompTox
DTXSID7031458
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
FDA UNII
C11E72455F
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
CHEBI
24814
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
NCI_THESAURUS
C1135
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
RXCUI
2598119
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
PUBCHEM
3712
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
EVMPD
SUB35050
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
NSC
525801
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY
MESH
C016517
Created by admin on Mon Mar 31 18:00:39 GMT 2025 , Edited by admin on Mon Mar 31 18:00:39 GMT 2025
PRIMARY